key: cord-0972697-12ou3bjk
authors: Jary, A.; Leducq, V.; Malet, I.; Marot, S.; Klement-Frutos, E.; Teyssou, E.; Soulié, C.; Abdi, B.; Wirden, M.; Pourcher, V.; Caumes, E.; Calvez, V.; Burrel, S.; Marcelin, A.-G.; Boutolleau, D.
title: Evolution of viral quasispecies during SARS-CoV-2 infection
date: 2020-07-24
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2020.07.032
sha: eb4b010c1c39efdb2bc702bdde850f95cbfdbc9f
doc_id: 972697
cord_uid: 12ou3bjk

OBJECTIVES: Studies are needed to better understand the genomic evolution of the recently emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study aimed to describe genomic diversity of SARS-CoV-2 by next generation sequencing (NGS) in a patient with longitudinal follow-up for SARS-CoV-2 infection. METHODS: Sequential samples collected from January, 29(th) to February, 4(th), 2020 in a patient infected by SARS-CoV-2 were used to perform amplification of two genome fragments including genes encoding Spike, Envelope, Membrane and Nucleocapsid proteins, and NGS with Illumina® technology. Phylogenetic analysis was performed with PhyML and viral variant identification with VarScan. RESULTS: Majority consensus sequences were identical in most of the samples (5/7) and differed with one synonymous mutation from the Wuhan reference sequence. We identified 233 variants; each sample harbored in median 38 different minority variants and only 4 were shared by different samples. The frequency of mutation was similar between genes and correlated to the gene length (r=0.93, p=0.0002). Most of mutations were substitution variations (n=217, 93.1%) and about 50% had moderate or high impact on gene expression. Viral variants also differed between lower and upper respiratory tract samples collected on the same day, suggesting independent sites of replication of SARS-CoV-2. CONCLUSION: We reported for the first time minority viral population representing up to 1% during the course of SARS-CoV-2 infection. Quasispecies were different from one day to the next, as well as between anatomical sites, suggesting that this new coronavirus appears as a complex and dynamic distributions of variants in vivo.

). Nodes presenting a branch support >70% are indicated by an asterisk. 311 

Genomic 200 characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient 201 with atypical pneumonia after visiting Wuhan

Human Coronavirus: Host-Pathogen Interaction

Coronavirus Disease 2019 patients. Clin Infect Dis Off Publ Infect Dis Soc 207 Am 2020

Temporal 209 profiles of viral load in posterior oropharyngeal saliva samples and serum antibody 210 responses during infection by SARS-CoV-2: an observational cohort study

The first 213 locally acquired novel case of 2019-nCoV infection in a healthcare worker in the Paris 214 area

SPAdes: 217 A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing

MAFFT multiple sequence alignment software version 7: 220 improvements in performance and usability

New 223 algorithms and methods to estimate maximum-likelihood phylogenies: assessing the 224 performance of PhyML 3.0

VarScan 2: 227 somatic mutation and copy number alteration discovery in cancer by exome sequencing

SARS-associated coronavirus quasispecies in individual 230 patients

Analysis of intrapatient 232 heterogeneity uncovers the microevolution of Middle East respiratory syndrome 233 coronavirus

Molecular characterization of SARS-CoV-2 from the first case of COVID-19 in Italy

RNA virus mutations and fitness for survival

Virological assessment of hospitalized patients with COVID-2019

Genomic variance of the 2019-nCoV coronavirus